Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest American Society for Bone and Mineral Research Stories

2013-12-05 08:31:02

Effort will spur drug development BETHESDA, Md., Dec. 5, 2013 /PRNewswire/ -- The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a three-year study to track the progression of osteoporosis more precisely and pave the way for more effective treatments. The study, which utilizes data from existing academic and clinical trials, is designed to establish the validity of specific imaging and biochemical markers for bone health....

2013-10-07 08:24:49

--Study is First to Analyze All Relevant Clinical Trials of Oral and Intranasal Calcitonin in Women-- BALTIMORE and PHILADELPHIA, Oct. 7, 2013 /PRNewswire/ -- Tarsa Therapeutics, Inc. today announced that it presented a new meta-analysis showing that salmon calcitonin does not appear to be associated with an increased risk of cancer in postmenopausal women. The meta-analysis was conducted using data derived from approximately 11,000 women in 24 randomized, controlled calcitonin trials that...

2011-09-19 08:07:26

Demonstrated superior efficacy to intranasal calcitonin with equivalent safety -- could represent new osteoporosis treatment option -- calcitonin has 30-year record of safety and efficacy but lack of oral form has limited its use Tarsa Therapeutics on Sunday presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis. These data were presented...

2011-09-19 06:00:00

SAN DIEGO, and PHILADELPHIA, Sept. 19, 2011 /PRNewswire/ -- Tarsa Therapeutics today reported that it presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA(TM), the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis. These data were presented at the American Society for Bone and Mineral Research 2011 Annual Meeting by ORACAL investigator Neil Binkley, MD, who is an Associate Professor of...

2010-10-19 17:04:53

A drug marketed to grow bone in osteoporosis patients also works to heal bone wounds in gum disease patients, a University of Michigan study suggests. "This new approach for the treatment of periodontal disease could allow us to rebuild some of the bone that is lost due to periodontal disease, which until this point has been very difficult to achieve," said Jill Bashutski, clinical assistant professor at the U-M School of Dentistry and first author on the study. "Current treatments to re-grow...

2010-10-16 15:45:00

EAST HANOVER, N.J., Oct. 16 /PRNewswire/ -- Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast® (zoledronic acid) injection in postmenopausal women with osteoporosis.(1) The study of more than 1,200 women was presented this weekend at the annual meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, ON, Canada. The study showed that Reclast maintained bone mass in...

2010-05-03 08:00:00

WASHINGTON, May 3 /PRNewswire/ -- This month the National Osteoporosis Foundation (NOF) will celebrate National Osteoporosis Awareness and Prevention Month in conjunction with a new campaign, called Healthy Bones, Build Them For Life®. As the nation's leading voluntary health organization solely dedicated to promoting lifelong bone health and fighting osteoporosis, NOF's goal is to reduce the widespread prevalence of osteoporosis and associated fractures and to find a cure...

2009-05-21 12:41:00

Congress Urged to Support Bill for Bone Health Promotion and Research WASHINGTON, May 21 /PRNewswire-USNewswire/ -- The National Osteoporosis Foundation (NOF) in conjunction with the National Coalition for Osteoporosis and Related Bone Diseases held a briefing on Capitol Hill today to engage Congress in an action plan for making bone health a national priority and encourage lawmakers to sign on to the "Bone Health Promotion and Research Act." The proposed legislation would create a...

2009-04-03 11:38:00

DXA Task Force Urges Congress to Pass Bill to Protect Patient Access WASHINGTON, April 3 /PRNewswire-USNewswire/ -- In an effort to protect patient access to osteoporosis testing and reduce the physical and economic burden of osteoporosis for millions of Americans, Congress introduced the "Medicare Fracture Prevention and Osteoporosis Testing Act of 2009," (S. 769 and H.R. 1894). Senators Blanche Lincoln (D-AR) and Olympia Snowe (R-ME) introduced the Senate version and Representatives...

2008-12-09 10:58:00

Medical Reference and Online Edition Gives Coverage of Bone and Mineral Diseases and Disorders with New International Drug Formulary WASHINGTON, Dec. 9 /PRNewswire/ -- The American Society for Bone and Mineral Research (ASBMR), the leading scientific organization for the study of bone diseases, announces the publication of the new seventh edition of the Primer on the Metabolic Bone Diseases and Disorders of Bone and Mineral Metabolism. The new edition reflects the rapid and exciting...